Review of interleukin-2 alone and interleukin-2/LAK clinical trials in metastatic malignant melanoma

Cancer Treat Rev. 1989 Jun:16 Suppl A:29-38. doi: 10.1016/0305-7372(89)90020-0.
No abstract available

Publication types

  • Clinical Trial
  • Review

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Clinical Trials as Topic
  • Drug Evaluation
  • Humans
  • Immunotherapy / methods
  • Interleukin-2* / administration & dosage
  • Interleukin-2* / adverse effects
  • Interleukin-2* / therapeutic use
  • Killer Cells, Natural / immunology*
  • Melanoma / drug therapy
  • Melanoma / secondary
  • Melanoma / therapy*

Substances

  • Antineoplastic Agents
  • Interleukin-2